Analysis of the correlation of GBP-2 expression and OS in 1879 patients also showed that high GBP-2 expression correlated with improved OS for a group including all breast cancers (Hazard ratio = 0.0.74 and 95% CI of 0.61–0.89) (Figure 1B). This evidence concerns the gene GBP2 and breast cancer.